Scholarlink

<p>Exosomes containing biomarkers offer potential for non-invasive diagnostics. For screening purposes and to improve patient treatment outcomes, early diagnosis of oral cancer is essential. This study's goal is to create a non-invasive assay using Janus particles (JPs) for detecting exosomes biomarkers CD63 and CD44 derived from the H357 oral cancer cell line. The JPs were functionalized with CD63 and CD44 antibodies to enable specific binding with target exosomes. The binding events were monitored through changes in rotational diffusivity, analyzed using cross-correlation techniques. The Stokes–Einstein–Debye model was used to correlate increasing exosome concentrations with slower particle rotation. The presence of the target biomarkers is confirmed with an enzyme-linked immunosorbent assay (ELISA). The JPs detected significant differences in rotational diffusivity between exosome binding antibodies with control group (PBS only) groups (p &lt; 0.05). The ELISA confirmed the presence of CD63 and CD44 biomarkers. The JPs based assay provides a high-sensitivity method for detecting oral cancer surface markers on exosomes. This technology shows promising potential as an effective and non-invasive method for oral cancer early screening and diagnosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Ultrasensitive detection of oral cancer biomarkers CD63 and CD44 in exosomes using janus particles: a rotational diffusometry-based assay

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月14日

查看全文
  • Fitri Nur Laily,
  • Vincent Santosa,
  • Thi Thanh Huong Pham,
  • Ymir M. Garcia,
  • Dhrubajyoti Das,
  • Aryan Morita,
  • Han-Sheng Chuang

摘要

Exosomes containing biomarkers offer potential for non-invasive diagnostics. For screening purposes and to improve patient treatment outcomes, early diagnosis of oral cancer is essential. This study's goal is to create a non-invasive assay using Janus particles (JPs) for detecting exosomes biomarkers CD63 and CD44 derived from the H357 oral cancer cell line. The JPs were functionalized with CD63 and CD44 antibodies to enable specific binding with target exosomes. The binding events were monitored through changes in rotational diffusivity, analyzed using cross-correlation techniques. The Stokes–Einstein–Debye model was used to correlate increasing exosome concentrations with slower particle rotation. The presence of the target biomarkers is confirmed with an enzyme-linked immunosorbent assay (ELISA). The JPs detected significant differences in rotational diffusivity between exosome binding antibodies with control group (PBS only) groups (p < 0.05). The ELISA confirmed the presence of CD63 and CD44 biomarkers. The JPs based assay provides a high-sensitivity method for detecting oral cancer surface markers on exosomes. This technology shows promising potential as an effective and non-invasive method for oral cancer early screening and diagnosis.